OS Therapies Announces Initial Closing of Warrant Exercise Inducement and Exchange Offer for Initial Gross Proceeds of Approximately $7.2 Million
OS Therapies closed the initial tranche of its warrant inducement and exchange offer, with seven of nine holders exercising or pre-funding warrants on 5,517,253 shares for $7.2 million in gross proceeds. The inducement cut the exercise price from $1.40 to $1.30 per share, and the participating holders received new warrants on the same 5.5 million shares at $1.40 — a re-loading of potential future dilution. The offer runs through October 30, 2026, so additional closings are possible. Proceeds, alongside $7 million in accrued refundable U.K.
Key figures
- Deal Value Usd
- 7200000
- Offering Price
- 1.3
- Shares Offered
- 5517253
- Offer expiry
- October 30, 2026
- Gross proceeds
- $7.2 million
- New warrant shares
- 5517253
- Holders participating
- 7 of 9
- Reduced exercise price
- $1.30 per share ($1.299 pre-funding)
- Prv reference sale value
- $203 million
- Accrued uk rd tax credits
- $7 million
- New warrant exercise price
- $1.40 per share
- Original warrant exercise price
- $1.40 per share
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.